Aided by a pipeline extending from in silico and biophysical integrated screening to high-resolution structure determination, we generated bifunctional PROTAC-fused hRpn13-targeting compounds that require an intact hRpn13 Pru domain to induce apoptosis in multiple myeloma cells. Here, ADRM1 is linked to plasma cell myeloma.